HCPCS code J9048 — Inj, bortezomib freseniuskab. Status: Active. Effective Jan 1, 2023. Source: CMS HCPCS Level II.

J9048

Active

Inj, bortezomib freseniuskab

Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jan 1, 2023
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9027

MUE — Medically Unlikely Edits

Maximum units of J9048 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 35
Outpatient Hospital 35
Practitioner Services 35

Source: CMS Medicare NCCI Medically Unlikely Edits

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2023-Q1
    Inj, bortezomib freseniuskab